RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on qualità of life in Parkinson’s disease
2009-01-01 Barone, P; Antonini, A; Colosimo, C; Marconi, R; Morgante, L; Avarello, Tp; Bottacchi, E; Cannas, A; Ceravolo, G; Ceravolo, R; Cicarelli, G; Gaglio, Rm; Giglia, Rm; Iemolo, F; Manfredi, M; Meco, G; Nicoletti, A; Pederzoli, M; Petrone, A; Pisani, A; Pontieri, Fe; Quatrale, R; Ramat, S; Scala, R; Volpe, G; Zappulla, S; Bentivoglio, Ar; Stocchi, F; Trianni, G; Dotto, Pd; PRIAMO study, Group
The relation between Parkinson's disease and ageing - Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects.
2013-01-01 Sale, P; De Pandis, Mf; Vimercati, Sl; Sova, I; Foti, C; Tenore, N; Fini, M; Stocchi, F; Albertini, G; Franceschini, M; Galli, M.
The relevance of dopaminergic level in nocturnal disability in Parkinson's disease: implications of continuous dopaminergic stimulation at night to treat the symptoms.
2014-01-01 Stocchi, F; Stirpe, P
The role of MAO-b inhibitors in the treatment of Parkinson's disease
1986-01-01 Ruggieri, S; Stocchi, F; Denaro, A; Baronti, F; Agnoli, A
The role of opicapone in the management of Parkinson's disease: an Italian consensus through a combined Nominal Group Technique and Delphi approach
2023-01-01 Antonini, A; Barone, P; Calabresi, P; Lopiano, L; Morgante, F; Pontieri, F E; Sensi, M; Stocchi, F
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease
1998-01-01 Schrag, Ae; Brooks, Dj; Brunt, E; Fuell, D; Korczyn, A; Poewe, W; Quinn, Np; Rascol, O; Stocchi, F
The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II
2022-01-01 Rocha, José-Francisco; Ebersbach, Georg; Lees, Andrew; Tolosa, Eduardo; Ferreira, Joaquim J; Poewe, Werner; Rascol, Olivier; Stocchi, Fabrizio; Antonini, Angelo; Magalhães, Diogo; Gama, Helena; Soares-da-Silva, Patrício
The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?
2018-01-01 Chou, Kl; Stacy, M; Simuni, T; Miyasaki, J; Oertel, Wh; Sethi, K; Fernandez, Hh; Stocchi, F
The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases
1999-01-01 Bonifati, V; Joosse, M; Nicholl, Dj; Vanacore, N; Bennett, P; Rizzu, P; Fabbrini, G; Marconi, R; Colosimo, C; Locuratolo, N; Stocchi, F; Bonuccelli, U; De Mari, M; Wenning, G; Vieregge, P; Oostra, B; Meco, G; Heutink, P
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s disease
2009-01-01 Stocchi, F
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on qualità of life in Parkinson’s disease | 1-gen-2009 | Barone, P; Antonini, A; Colosimo, C; Marconi, R; Morgante, L; Avarello, Tp; Bottacchi, E; Cannas, A; Ceravolo, G; Ceravolo, R; Cicarelli, G; Gaglio, Rm; Giglia, Rm; Iemolo, F; Manfredi, M; Meco, G; Nicoletti, A; Pederzoli, M; Petrone, A; Pisani, A; Pontieri, Fe; Quatrale, R; Ramat, S; Scala, R; Volpe, G; Zappulla, S; Bentivoglio, Ar; Stocchi, F; Trianni, G; Dotto, Pd; PRIAMO study, Group | |
The relation between Parkinson's disease and ageing - Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects. | 1-gen-2013 | Sale, P; De Pandis, Mf; Vimercati, Sl; Sova, I; Foti, C; Tenore, N; Fini, M; Stocchi, F; Albertini, G; Franceschini, M; Galli, M. | |
The relevance of dopaminergic level in nocturnal disability in Parkinson's disease: implications of continuous dopaminergic stimulation at night to treat the symptoms. | 1-gen-2014 | Stocchi, F; Stirpe, P | |
The role of MAO-b inhibitors in the treatment of Parkinson's disease | 1-gen-1986 | Ruggieri, S; Stocchi, F; Denaro, A; Baronti, F; Agnoli, A | |
The role of opicapone in the management of Parkinson's disease: an Italian consensus through a combined Nominal Group Technique and Delphi approach | 1-gen-2023 | Antonini, A; Barone, P; Calabresi, P; Lopiano, L; Morgante, F; Pontieri, F E; Sensi, M; Stocchi, F | |
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease | 1-gen-1998 | Schrag, Ae; Brooks, Dj; Brunt, E; Fuell, D; Korczyn, A; Poewe, W; Quinn, Np; Rascol, O; Stocchi, F | |
The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II | 1-gen-2022 | Rocha, José-Francisco; Ebersbach, Georg; Lees, Andrew; Tolosa, Eduardo; Ferreira, Joaquim J; Poewe, Werner; Rascol, Olivier; Stocchi, Fabrizio; Antonini, Angelo; Magalhães, Diogo; Gama, Helena; Soares-da-Silva, Patrício | |
The spectrum of "off" in Parkinson's disease: What have we learned over 40 years? | 1-gen-2018 | Chou, Kl; Stacy, M; Simuni, T; Miyasaki, J; Oertel, Wh; Sethi, K; Fernandez, Hh; Stocchi, F | |
The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases | 1-gen-1999 | Bonifati, V; Joosse, M; Nicholl, Dj; Vanacore, N; Bennett, P; Rizzu, P; Fabbrini, G; Marconi, R; Colosimo, C; Locuratolo, N; Stocchi, F; Bonuccelli, U; De Mari, M; Wenning, G; Vieregge, P; Oostra, B; Meco, G; Heutink, P | |
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s disease | 1-gen-2009 | Stocchi, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 310
- 1 Contributo su Rivista::1.1 Arti... 310
Data di pubblicazione
- In corso di stampa 1
- 2020 - 2023 67
- 2010 - 2019 99
- 2000 - 2009 74
- 1990 - 1999 44
- 1984 - 1989 25
Rivista
- MOVEMENT DISORDERS 54
- CLINICAL NEUROPHARMACOLOGY 20
- PARKINSONISM & RELATED DISORDERS 17
- NEUROLOGICAL SCIENCES 14
- NEUROLOGY 13
- EUROPEAN JOURNAL OF NEUROLOGY 12
- ADVANCES IN NEUROLOGY 9
- JOURNAL OF NEUROLOGY 9
- FUNCTIONAL NEUROLOGY 8
- EXPERT OPINION ON PHARMACOTHERAPY 7
Keyword
- Parkinson's disease 20
- Parkinson’s disease 13
- motor fluctuations 10
- levodopa 7
- Levodopa 4
- opicapone 4
- pharmacokinetics 4
- resting state electroencephalogra... 4
- Aged 3
- Alzheimer’s disease 3
Lingua
- eng 308
- ita 1
Accesso al fulltext
- no fulltext 305
- reserved 5